L. Zyme - Future Formulations | DrugInfo.In

L. Zyme - Future Formulations

The drug brand named L. Zyme contains generic salt-Amylase (Aspergillus Oryzae) and is manufactured by Future Formulations.
L. Zyme is mainly associated with symptoms and indications-The International Classification of Diseases (ICD)- A09AA02-Multienzymes (lipase, protease etc.).

Generic Salts


Amylase (Aspergillus Oryzae)
Cellulase (Aspergillus Niger)
Invertase (Saccharomyces sp.)
Lactase (Aspergillus Oryzae)
Lipase (Aspergillus Niger)
Protease (Aspergillus Oryzae)

Available types of drugs

Capsules; Oral; Amylase (Aspergillus Oryzae) 6666.6 units; Cellulase (Aspergillus Niger) 1093.3 units; Invertase (Saccharomyces sp.) 3.5 units; Lactase (Aspergillus Oryzae) 1000 units; Lipase (Aspergillus Niger) 255.5 units; Protease (Aspergillus Oryzae) 50,000 units

Medical categories

Human Drug
Digestants
Enzymes

Usage-Diseases

A09AA02-Multienzymes (lipase, protease etc.)
Manufacturers

Future Formulations

More Drugs